Suchergebnisse - "Taub, Jeffrey W"

PubPharm (81)

1

Curing childhood cancer the "Natural" Way : Nature as the source of chemotherapy agents

enthalten in: Biochemical pharmacology | 2023

von Al-Antary, E. | Gupte, A. | Carter, J. | +5

2

c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia

enthalten in: Apoptosis : an international journal on programmed cell death | 2022

von Liu, S. | Qiao, X. | Wu, S. | +8

3

Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia

enthalten in: Biochemical pharmacology | 2022

von Hege Hurrish, K. | Qiao, X. | Li, X. | +13

4

Meditation reduces brain activity in the default mode network in children with active cancer and survivors

enthalten in: Pediatric blood & cancer | 2022

von Hehr, A. | Iadipaolo, A. | Morales, A. | +7

5

Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

enthalten in: Cells | 2022

von Wu, S. | Edwards, H. | Wang, D. | +7

6

The paradox of Myeloid Leukemia associated with Down syndrome

enthalten in: Biochemical pharmacology | 2022

von Gupte, A. | Al-Antary, E. | Edwards, H. | +3

7

Slow Transcription of the 99a/let-7c/125b-2 Cluster Results in Differential MiRNA Expression and Promotes Melanoma Phenotypic Plasticity

enthalten in: The Journal of investigative dermatology | 2021

von Sheinboim, D. | Parikh, S. | Parikh, R. | +15

8

When it comes to drug access, should children be considered small adults? Countering coverage denials of FLT3 inhibitors in children with FLT3-ITD AML

enthalten in: Pediatric blood & cancer | 2021

von Knight, T. | Ge, Y. | Taub, J. | +2

9

Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation

enthalten in: Pediatric blood & cancer | 2021

von Persaud, Y. | Seddiq, M. | Wu, Y. | +6

10

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

enthalten in: Blood cancer journal | 2021

von Qiao, X. | Ma, J. | Knight, T. | +14

1
2
3
4
5
6
7
8
9
Nächster »
[9]